BEPRIDIL - A PHARMACOLOGICAL REAPPRAISAL OF ITS POTENTIAL BENEFICIAL-EFFECTS IN ANGINA AND TISSUE PROTECTION FOLLOWING ISCHEMIA

被引:11
|
作者
MASSINGHAM, R
VANZWIETEN, PA
机构
关键词
D O I
10.1007/BF01857623
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:731 / 742
页数:12
相关论文
共 15 条
  • [1] BENEFICIAL-EFFECTS OF AUTOTRANSPLANTED MUSCLE-TISSUE ON RETICULOENDOTHELIAL FUNCTION FOLLOWING SPLENECTOMY
    CHAUDRY, IH
    CLEMENS, MG
    SCHLECK, SA
    BAUE, AE
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1982, 22 (07): : 611 - 611
  • [2] STUDIES ON THE MECHANISM OF BENEFICIAL-EFFECTS OF ATP-MGCL2 FOLLOWING HEPATIC ISCHEMIA
    OHKAWA, M
    CLEMENS, MG
    CHAUDRY, IH
    AMERICAN JOURNAL OF PHYSIOLOGY, 1983, 244 (05): : R695 - R702
  • [3] EVIDENCE OF CRYO-IMMUNOLOGIC REACTION FOLLOWING CRYOSURGERY AND ITS BENEFICIAL-EFFECTS
    ABLIN, RJ
    CRYOBIOLOGY, 1978, 15 (06) : 701 - 701
  • [4] BENEFICIAL-EFFECTS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-ISCHEMIA IN CATS
    DARIUS, H
    YANAGISAWA, A
    BREZINSKI, ME
    HOCK, CE
    LEFER, AM
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (01) : 125 - 131
  • [5] BENEFICIAL-EFFECTS OF IMPLANTED MUSCLE-TISSUE ON PULMONARY PARTICULATE RETENTION AND SURVIVAL FOLLOWING SPLENECTOMY
    CHAUDRY, IH
    CLEMENS, MG
    SCHLECK, S
    KOVACS, K
    BAUE, AE
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1983, 23 (07): : 584 - 590
  • [6] BENEFICIAL-EFFECTS OF THE ENDOTHELIN RECEPTOR ANTAGONIST BOSENTAN ON MYOCARDIAL AND ENDOTHELIAL INJURY FOLLOWING ISCHEMIA-REPERFUSION IN THE RAT
    LI, XS
    WANG, QD
    PERNOW, J
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 283 (1-3) : 161 - 168
  • [7] BENEFICIAL-EFFECTS OF ATRIAL-NATRIURETIC-PEPTIDE ON EXERCISE-INDUCED MYOCARDIAL-ISCHEMIA IN PATIENTS WITH STABLE EFFORT ANGINA-PECTORIS
    LAI, CP
    EGASHIRA, K
    TASHIRO, H
    NARABAYASHI, H
    KOYANAGI, S
    IMAIZUMI, T
    TAKESHITA, A
    CIRCULATION, 1993, 87 (01) : 144 - 151
  • [9] The beneficial pharmacological effects and potential mechanisms of picroside II: Evidence of its benefits from in vitro and in vivo
    Ma, Shangying
    Wang, Xueyi
    Lai, Feifan
    Lou, Chenghua
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 130
  • [10] DOES TISSUE-TYPE PLASMINOGEN-ACTIVATOR HAVE DIRECT BENEFICIAL-EFFECTS ON THE MYOCARDIUM INDEPENDENT OF ITS ABILITY TO LYSE INTRACORONARY THROMBI
    KLONER, RA
    ALKER, K
    CAMPBELL, C
    FIGURES, G
    EISENHAUER, A
    HALE, S
    CIRCULATION, 1989, 79 (05) : 1125 - 1136